Clinical Trial Update: Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a sirolimus-eluting collagen implant for arteriovenous fistula outcomes has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Sirolimus-eluting collagen implant (sirolimus)

Snippet

Sponsor: Vascular Therapies, Inc. | Conditions: Complication of Renal Dialysis, End Stage Renal Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-10-09